Apellis Pharmaceuticals, Inc. (APLS)

40.90 +0.03 (+0.07%) USD  |  NASDAQ  |  Apr 17, 16:00
40.90 0.00 (0.00%) After-Hours: 20:00
More

Apellis Pharmaceuticals Total Operating Expenses (% of Quarterly Revenues)

Total Operating Expenses (% of Quarterly Revenues) Chart

View Total Operating Expenses (% of Quarterly Revenues) for APLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Operating Expenses (% of Quarterly Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years

View Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Operating Expenses (% of Quarterly Revenues) Benchmarks

View Total Operating Expenses (% of Quarterly Revenues) Benchmarks
Start Trial
Biogen, Inc. Upgrade
Eli Lilly & Co. Upgrade
Agios Pharmaceuticals, Inc. Upgrade
Scholar Rock Holding Corp. --
BridgeBio Pharma, Inc. Upgrade